Verapamil hydrochloride (VP; Sigma-Aldrich, Australia), mibefradil hydrochloride (MF; Tocris Bioscience, UK), L703,606 (L7; Sigma-Aldrich, Australia), and primaquine (PQ; World Wide Antimalarial Resistance Network [WWARN] QA/QC Reference Material Programme [42 (link)]) were selected as CQ resistance reversal agents (CQRRAs) in this study. The intrinsic antimalarial activities of the recently reported MF and L7 had hitherto been tested only in the CQr strain K1 (28 (link)). Therefore, prior to the experiments in field isolates, the intrinsic antimalarial properties of these reversal agents, in addition to those of VP and PQ, were assessed in CQr (K1 and W2) and CQs (3D7 and FC27) P. falciparum laboratory strains (BEI Resources, ATCC, Manassas, VA, USA).
Free full text: Click here